Advinus Therapeutics and Celgene Global Health Initiate Research and Develo...
Advinus' GK-activator Achieves Early POC for Diabetes...
Advinus, SignalChem to work on new anti-cancer drugs...
View More News
BIO International Convention, MA, 18-21 June 2012
More
To be updated soon
Metabolic Diseases
Inflammatory Diseases
Neglected Diseases
Process Development & Synthesis
Analytical R&D
DMPK
Bioanalytical
Safety Assessment
Safety Pharmacology
Clinical Pharmacology
Process Chemistry Services
Formulation Development
Physico/Chemical
Residue Analytical
E-fate & ADME
Toxicology
Home
|
Sitemap
|
Contact Us
© 2008 Advinus Therapeutics, All Rights Reserved.